Detailed information for compound 73611
Basic information
Technical information
- TDR Targets ID: 73611
- Name: N-[2-[(3S,4R)-3-benzyl-4-hydroxy-3,4-dihydro- 2H-chromen-7-yl]-4-fluorophenyl]-1,1,1-triflu oromethanesulfonamide
- MW: 481.46 | Formula: C23H19F4NO4S
-
H donors: 2
H acceptors: 3
LogP: 4.93
Rotable bonds: 6
Rule of 5 violations (Lipinski): 1 - SMILES: Fc1ccc(c(c1)c1ccc2c(c1)OC[C@@H]([C@H]2O)Cc1ccccc1)NS(=O)(=O)C(F)(F)F
- InChi: 1S/C23H19F4NO4S/c24-17-7-9-20(28-33(30,31)23(25,26)27)19(12-17)15-6-8-18-21(11-15)32-13-16(22(18)29)10-14-4-2-1-3-5-14/h1-9,11-12,16,22,28-29H,10,13H2/t16-,22+/m0/s1
- InChiKey: DRFBYJUAOGDDQU-KSFYIVLOSA-N
Network
Hover on a compound node to display the structore
Synonyms
- N-[2-[(3S,4R)-3-benzyl-4-hydroxy-chroman-7-yl]-4-fluoro-phenyl]-1,1,1-trifluoro-methanesulfonamide
- N-[2-[(3S,4R)-3-benzyl-4-hydroxy-3,4-dihydro-2H-1-benzopyran-7-yl]-4-fluorophenyl]-1,1,1-trifluoromethanesulfonamide
- 1,1,1-trifluoro-N-[4-fluoro-2-[(3S,4R)-4-hydroxy-3-(phenylmethyl)-3,4-dihydro-2H-chromen-7-yl]phenyl]methanesulfonamide
- 1,1,1-trifluoro-N-[4-fluoro-2-[(3S,4R)-4-hydroxy-3-(phenylmethyl)chroman-7-yl]phenyl]methanesulfonamide
- 1,1,1-trifluoro-N-[4-fluoro-2-[(3S,4R)-4-hydroxy-3-(phenylmethyl)-7-chromanyl]phenyl]methanesulfonamide
- N-[2-[(3S,4R)-3-(benzyl)-4-hydroxy-chroman-7-yl]-4-fluoro-phenyl]-1,1,1-trifluoro-methanesulfonamide
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Homo sapiens | leukotriene B4 receptor | Starlite/ChEMBL | References |
Predicted pathogen targets for this compound
By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Echinococcus multilocularis | thymidine phosphorylase | 0.2746 | 1 | 0.5 |
| Mycobacterium ulcerans | thymidine phosphorylase | 0.2746 | 1 | 1 |
| Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.0775 | 0 | 0.5 |
| Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.2746 | 1 | 1 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| IC50 (binding) | = 3.8 nM | Ability to inhibit LTB4 binding to LTB receptors on isolated human neutrophils. | ChEMBL. | 9873433 |
| IC50 (binding) | = 3.8 nM | Ability to inhibit LTB4 binding to LTB receptors on isolated human neutrophils. | ChEMBL. | 9873433 |
| IC50 (functional) | = 15 nM | Ability to inhibit LTB4-induced chemotaxis of isolated human neutrophils. | ChEMBL. | 9873433 |
| IC50 (functional) | = 15 nM | Ability to inhibit LTB4-induced chemotaxis of isolated human neutrophils. | ChEMBL. | 9873433 |
| IC50 (functional) | = 44 nM | Ability to inhibit LTB4-induced chemotaxis of isolated human neutrophils. | ChEMBL. | 9873433 |
| IC50 (functional) | = 44 nM | Ability to inhibit LTB4-induced chemotaxis of isolated human neutrophils. | ChEMBL. | 9873433 |
| IC50 (binding) | = 50 nM | Ability to inhibit LTB4 binding to LTB receptors on isolated human neutrophils. | ChEMBL. | 9873433 |
| IC50 (binding) | = 50 nM | Ability to inhibit LTB4 binding to LTB receptors on isolated human neutrophils. | ChEMBL. | 9873433 |
| IC50 (functional) | = 330 nM | Ability to inhibit LTB4-induced CD11b up-regulation on isolated human neutrophils in whole blood | ChEMBL. | 9873433 |
| IC50 (functional) | = 330 nM | Ability to inhibit LTB4-induced CD11b up-regulation on isolated human neutrophils in whole blood | ChEMBL. | 9873433 |
| IC50 (functional) | = 360 nM | Ability to inhibit LTB4-induced CD11b up-regulation on isolated human neutrophils | ChEMBL. | 9873433 |
| IC50 (functional) | = 360 nM | Ability to inhibit LTB4-induced CD11b up-regulation on isolated human neutrophils | ChEMBL. | 9873433 |
| IC50 (functional) | > 3000 nM | Ability to inhibit LTB4-induced CD11b up-regulation on isolated human neutrophils | ChEMBL. | 9873433 |
| IC50 (functional) | > 3000 nM | Ability to inhibit LTB4-induced CD11b up-regulation on isolated human neutrophils in whole blood | ChEMBL. | 9873433 |
| IC50 (functional) | > 3000 nM | Ability to inhibit LTB4-induced CD11b up-regulation on isolated human neutrophils | ChEMBL. | 9873433 |
| IC50 (functional) | > 3000 nM | Ability to inhibit LTB4-induced CD11b up-regulation on isolated human neutrophils in whole blood | ChEMBL. | 9873433 |
| Ratio (functional) | = 0.9 | Ratio of CD11b(WB) IC50 to CD11b (IC)IC50 | ChEMBL. | 9873433 |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- PubChem: 9934899
Bibliographic References
1 literature reference was collected for this gene.
If you have references for this compound, please enter them in a user comment (below) or Contact us.